Skip to Content

Does JAKi Increase the Risk of Cancer in Patients with RA?

Do we need to be aware of cancer risk when treating janus kinase inhibitors (JAKi)? Let Rasmus Westermann, MD, present his study investigating cancer risk in patients with rheumatoid arthritis (RA) treated with JAKi compared to biologics.

Rasmus Westermann

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top